Skip to main content
Pierrel logo

Pierrel — Investor Relations & Filings

Ticker · PRL ISIN · IT0005549644 LEI · 8156002BC7CB6E3BD403 XMIL Manufacturing
Open in API
Filings indexed 577 across all filing types
Latest filing 2017-08-07 Legal Proceedings Report
Country IT Italy
Listing XMIL PRL

About Pierrel

https://www.pierrelgroup.com/en/

Pierrel is a global pharmaceutical company specializing in oral health. With over 70 years of experience, the company focuses on the development, production, registration, and licensing of dental anesthetics and complementary medical devices. Its core expertise lies in the aseptic manufacturing of injectable drugs. The product portfolio includes a wide range of dental anesthetics marketed under its own brands, such as Orabloc®, Ubisestin™, Xylestesin™, and Mepivastesin™. In addition to its branded products, Pierrel offers medical devices for oral pathology screening, prevention, and regeneration. The company also provides contract manufacturing services to the pharmaceutical and life science industries. Its production facilities are authorized by major global regulatory agencies, including the EMA and FDA, ensuring compliance with high international quality standards.

Recent filings

Filing Released Lang Actions
Pierrel S.p.A.: Accettata l’offerta di Fin Posillipo S.p.A. e Bootes S.r.l. per l’acquisto dei crediti vantati da Unicredit, BNL e BPM vs Pierrel
Legal Proceedings Report Classification · 1% confidence The document is an official communication from Pierrel S.p.A. dated August 7, 2017, identified by the header 'Informazione Regolamentata' (Regulated Information) and the type 'REGEM'. The subject matter concerns the acceptance of an offer by controlling shareholders to purchase significant company debts from banks, which is a critical financial and corporate restructuring event. This type of announcement, detailing significant corporate actions, financing arrangements, or material events that are not standard periodic reports (like 10-K or IR) or simple dividend/insider trades, typically falls under general regulatory announcements. Since the content details a major transaction related to debt restructuring and capital maintenance (avoiding liquidation based on Italian Civil Code Article 2447), it is a significant corporate event disclosure. Given the options, it is not a standard Earnings Release (ER), Interim Report (IR), or a specific financing announcement (CAP), but rather a material disclosure of a transaction impacting the company's financial stability and structure. In the context of mandatory disclosures that don't fit the highly specific categories, 'Regulatory Filings' (RNS) serves as the appropriate general category for material, non-standard regulatory news releases.
2017-08-07 Italian
Pierrel S.p.A.: Informativa mensile ai sensi dell’art. 114, comma 5, D.Lgs. N. 58/98
Regulatory Filings Classification · 1% confidence The document is a monthly financial disclosure ('Informativa mensile') issued by Pierrel S.p.A. in compliance with Article 114 of the Italian Legislative Decree 58/98. It provides a detailed breakdown of the company's net financial position (Net Debt) as of June 30, 2017, including tables comparing current and non-current liabilities. While it contains financial data, it is a recurring regulatory disclosure required by the market regulator (Consob) rather than a full quarterly or annual report. Therefore, it falls under the category of general regulatory filings. H1 2017
2017-07-31 Italian
Pierrel S.p.A:: Riunito il Consiglio di Amministrazione di Pierrel S.p.A. - Aggiornamento calendario eventi societari
Share Issue/Capital Change Classification · 1% confidence The document is a press release from Pierrel S.p.A. dated July 14, 2017. The subject ('Oggetto') is 'Pierrel S.p.A:: Riunito il Consiglio di Amministrazione di Pierrel S.p.A. - Aggiornamento calendario eventi societari' (Board of Directors meeting - Update on corporate event calendar). The text discusses updates related to debt negotiations, a potential capital increase deadline (August 10, 2017), and crucially, it announces a postponement and rescheduling of future board meetings intended to approve financial statements (FY 2016 and Q1 2017 interim report) and a subsequent shareholders' meeting. Since this document is an announcement updating the market on the timing of future corporate events and financial report releases, rather than the reports themselves, it fits best under the category for announcing the publication of reports or general regulatory updates. Given that it specifically deals with rescheduling the release of financial reports and corporate actions, it is a regulatory announcement. Since it is not a specific filing like 10-K, ER, or IR, and it is an announcement about corporate events and reporting schedules, it aligns closely with a general regulatory filing or an announcement regarding report publication. Because it is primarily communicating a change in the schedule for approving and releasing financial documents (Bilancio, Rendiconto intermedio), it is a form of Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Given the specific nature of rescheduling financial report approvals, RPA is a strong candidate, but RNS serves as the best general regulatory announcement fallback when the specific timing of a report release is the main subject, especially when it's not the report itself. However, the content is a direct update to the market regarding the timeline for approving and releasing financial results and shareholder meetings, which is a core function of regulatory disclosure. Since it is not a formal 'Earnings Release' (ER) or 'Interim Report' (IR), but an announcement *about* when those things will happen, and it is a formal communication to the market (REGEM type), RNS (Regulatory Filings) is the most appropriate general classification for this type of procedural update, although RPA is also plausible. I will select RNS as the most encompassing regulatory update category for this specific rescheduling notice.
2017-07-14 Italian
Pierrel S.p.A.: Riunito il Consiglio di Amministrazione di Pierrel S.p.A. - Aggiornamento calendario eventi societari
Report Publication Announcement Classification · 1% confidence The document is an official communication from Pierrel S.p.A. dated June 30, 2017, identified by the header 'Informazione Regolamentata' and 'Oggetto: Pierrel S.p.A.: Riunito il Consiglio di Amministrazione di Pierrel S.p.A. - Aggiornamento calendario eventi societari'. The content discusses the postponement of the approval of the draft financial statements (for FY 2016) and the voluntary interim report (as of March 31, 2017) until a later date in July, following discussions with shareholders regarding the company's financial situation. This is a formal announcement regarding corporate events and financial reporting schedules, rather than the reports themselves. Since it is a formal, mandatory regulatory announcement that doesn't fit specific categories like Director's Dealing (DIRS), Dividend (DIV), or Earnings Release (ER), it falls best under the general 'Regulatory Filings' category (RNS) as a miscellaneous regulatory update, or potentially a Report Publication Announcement (RPA) if it were announcing the *publication* of a report, but here it announces a *delay* in publication/approval. Given the nature of updating the market on board decisions affecting financial reporting timelines, RNS is the most appropriate general regulatory filing code.
2017-06-30 Italian
Pierrel S.p.A.:Informativa mensile ai sensi dell’art. 114, comma 5, D.Lgs. N. 58/98
Regulatory Filings Classification · 1% confidence The document is a monthly disclosure report ('Informativa mensile') issued by Pierrel S.p.A. in compliance with Article 114, paragraph 5, of Legislative Decree No. 58/98. It provides detailed financial data, specifically the Net Financial Position (Posizione Finanziaria Netta) for the Group and the parent company as of May 31, 2017, along with a narrative explanation of the company's financial situation, debt restructuring negotiations, and board activities. While it contains financial data, it is a recurring regulatory disclosure rather than a full quarterly or annual financial report. Given the specific regulatory requirement and the nature of the disclosure, it fits best under 'Regulatory Filings' as a general compliance document. FY 2017
2017-06-30 Italian
Pierrel S.p.A.: SOTTOSCRITTO UN PROTOCOLLO D’INTESA TRA GLI AZIONISTI FIN POSILLIPO S.P.A. E BOOTES S.R.L.
M&A Activity Classification · 1% confidence The document is an official communication from Pierrel S.p.A. (indicated by the metadata 'Informazione Regolamentata' and 'REGEM' type) announcing that two major shareholders (Fin Posillipo S.p.A. and Bootes S.r.l.) have signed a 'Protocollo d'Intesa' (Memorandum of Understanding). This agreement details commitments regarding debt restructuring, capital increases, and crucially, the terms of a future 'patto parasociale' (shareholders' agreement) governing board composition and share transfer restrictions. The document explicitly states that an extract of the agreement concerning the shareholders' agreement is being published in compliance with Italian regulations (Consob resolutions, D.Lgs. 58/1998). Since the core subject is the agreement between shareholders that dictates future corporate governance and shareholding structure, this falls under the scope of agreements that influence control or significant ownership. While it relates to governance (CGR) and major shareholdings (MRQ), the specific focus on a binding agreement between controlling/significant shareholders regarding governance and share transfer rights, published as a regulatory disclosure, aligns most closely with documents detailing shareholder arrangements. However, given the options, the content is primarily about the structure of control and future voting/governance arrangements resulting from a shareholder pact. This type of disclosure, detailing governance arrangements resulting from a pact between shareholders, is often classified under Governance Information (CGR) or sometimes as a specific type of regulatory filing (RNS) if no better fit exists. Since it details internal rules and board structure influence, CGR is a strong candidate. However, the document is a formal regulatory announcement ('Comunicato stampa' filed via 'REGEM') detailing a binding agreement between shareholders that dictates governance, which is a key component of corporate governance reporting. Given the detailed nature of the governance provisions (board composition, voting lists), Governance Information (CGR) is the most appropriate specific classification over the general Regulatory Filing (RNS). The document is not a short announcement of a report (RPA), but the report itself (the announcement of the agreement).
2017-06-13 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.